An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

About the study

The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.

Study point of contact

Sherif M Badawy, MD, MS
(312) 227-4836
[email protected]
Kathryn King, BS
(312) 227-4825
[email protected]


12 Years - 21 Years


Not Applicable

Study type






participation requirements

Age 12-21 years old
Any sickle cell disease genotype
On steady state of hydroxyurea for 2 months
Own of have access to a smartphone during the study period

participation restrictions

Recent hospitalizations within the past 7 days

Last updated 2022-03-07